CD4 and chronic obstructive pulmonary disease: In addition, there were no statistically significant differences in other clinical indicators such as gender, BMI, chronic obstructive pulmonary disease, hypertension, PS score, CD8+T cell count and CD4+/CD8+T cell ratio between the two groups (Table 2).